The combination of nifedipine and propranolol in the management of patients with angina pectoris

British Journal of Clinical Pharmacology
A C TweddelI Hutton

Abstract

1 A double-blind cross over study was carried out to assess the effects of the combination of nifedipine and propranolol in 25 patients with chronic stable angina pectoris at beta-adrenoceptor blockade. 2 Efficacy was judged objectively by a standardized exercise protocol using a bicycle ergometer and subjectively by patient assessment of anginal attack rate. 3 The combination of nifedipine and propranolol was shown to be effective with an increase in exercise time to angina and an increase in physical work capacity expressed in terms of calculated maximal oxygen uptake (VO2 max). There was an associated reduction in anginal attack rate. 4 The synergistic effect was even more pronounced after reduction in propranolol dosage to 50% of the beta-adrenoceptor blocking dose, reflecting the myocardial depressant effects of beta-adrenoceptor blocking drugs in these patients with coronary heart disease, some of whom had poor left ventricular function.

References

Jun 9, 1979·British Medical Journal·G D OakleyA P Selwyn
Oct 22, 1979·The American Journal of Cardiology·F A Heupler, W L Proudfit
Dec 1, 1978·British Heart Journal·K M FoxJ P Shillingford
Feb 28, 1975·European Journal of Clinical Pharmacology·J H AtterhögA L Melin
Oct 11, 1975·Annals of Internal Medicine·M H CrawfordJ Ross
Sep 26, 1970·British Medical Journal·D J Coltart, D G Shand
Apr 1, 1971·The American Journal of Cardiology·E Braunwald
Dec 1, 1967·Annals of Internal Medicine·R E GianellyD C Harrison
May 6, 1971·The New England Journal of Medicine·J H Mitchell, G Blomqvist
Sep 1, 1966·The American Journal of Cardiology·J Hamer, E Sowton
Apr 1, 1980·British Heart Journal·S KlugmannF Camerini

❮ Previous
Next ❯

Citations

Aug 1, 1990·Cardiovascular Drugs and Therapy·D G Waller, V F Challenor
Jan 1, 1985·European Journal of Clinical Pharmacology·J P van MantgemA W Matroos
Jun 1, 1984·British Journal of Clinical Pharmacology·B SilkeS H Taylor
Jan 24, 2014·Nursing Research and Practice·Jeffrey W Young, Sheila Melander
Nov 1, 1989·British Journal of Clinical Pharmacology·V F ChallenorC F George
Mar 1, 1985·British Journal of Clinical Pharmacology·A P RaeI Hutton
Nov 1, 1984·British Journal of Clinical Pharmacology·B SilkeS H Taylor
Mar 16, 1989·The New England Journal of Medicine·M Packer
Feb 1, 1982·British Journal of Clinical Pharmacology·B C Campbell
Feb 4, 1999·Hypertension·W B StasonT C Chalmers
Jun 1, 1989·Cardiovascular Drugs and Therapy·V F ChallenorC F George
Jan 1, 1985·Clinical and Experimental Hypertension. Part A, Theory and Practice·P LejeuneU Schreiber
Oct 1, 1982·Australian and New Zealand Journal of Medicine·M F O'Rourke
Jan 1, 1991·European Journal of Clinical Pharmacology·S H Thomas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.